Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Riboflavin transporters are membrane proteins belonging to the solute carrier family 52 (SLC52) responsible for the active, carrier-mediated uptake of riboflavin (vitamin B₂) from the extracellular space into cells. There are three characterized human riboflavin transporters (RFVT1/SLC52A1, RFVT2/SLC52A2, RFVT3/SLC52A3), each with different tissue expression profiles and physiological roles. Riboflavin is essential for the synthesis of flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN), cofactors required in a diverse range of enzymatic redox reactions involved in energy metabolism and antioxidant defense. Genetic defects in riboflavin transporters result in cellular riboflavin deficiency and are the cause of rare neurodegenerative conditions such as Brown-Vialetto-Van Laere syndrome. Riboflavin supplementation is currently the standard therapy for these transporter deficiencies, with efficacy depending on residual transporter function.
Therapeutic riboflavin acts as a substrate for these transporters, correcting deficiency due to transporter dysfunction. Inhibitors (in microorganisms) block riboflavin uptake.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Riboflavin transporter (RFVT1, RFVT2, RFVT3).